Table 2.
Mass contents of phospholipid molecular species in the DRG of wild-type and apolipoprotein E knockout mice at 4 months of agea
|
Molecular species |
WT mice |
ApoE KO mice |
---|---|---|---|
[M - H]− | Phosphatidic acid (GPA) | ||
671.5 | 16:0−18:2 GPA | 0.3 ± 0.1 | 0.3 ± 0.1 |
673.5 | 16:0−18:1 GPA | 0.2 ± 0.1 | 0.2 ± 0.1 |
699.5 | 18:1−18:1 GPA | 0.6 ± 0.1 | 0.5 ± 0.1 |
701.5 | 18:0−18:1 GPA | 2.2 ± 0.2 | 1.9 ± 0.2 |
Total GPA | 3.2 ± 0.2 | 3.0 ± 0.3 |
[M - H]− | Phosphatidylglycerol (GPGro) | ||
---|---|---|---|
745.5 | 16:0−18:2 GPGro | 0.1 ± 0.1 | 0.1 ± 0.1 |
747.5 | 16:0−18:1 GPGro | 0.5 ± 0.1 | 0.5 ± 0.1 |
771.5 | 18:1−18:2 GPGro | 0.3 ± 0.1 | 0.2 ± 0.1 |
773.5 | 18:1−18:1 GPGro | 0.2 ± 0.1 | 0.2 ± 0.1 |
775.5 | 18:0−18:2 GPGro | DA | DA |
Total GPGro | 1.0 ± 0.1 | 1.0 ± 0.1 |
[M - H]− | Serine glycerophospholipid (GPSer) | ||
---|---|---|---|
758.5 | 16:0−18:2 | 0.3 ± 0.1 | 0.3 ± 0.1 |
760.5 | 16:0−18:1 | 1.8 ± 0.2 | 2.2 ± 0.1 |
770.6 | p18:1−18:1 | 0.7 ± 0.2 | 0.9 ± 0.2 |
772.6 | p18:0−18:1 | 2.8 ± 0.2 | 2.9 ± 0.1 |
774.6 | p18:0−18:0 | 1.8 ± 0.2 | 1.9 ± 0.1 |
786.6 | 18:1−18:1 | 16.5 ± 0.3 | 17.2 ± 0.5 |
788.6 | 18:0−18:1 | 74.1 ± 0.8 | 71.8 ± 2.8 |
810.6 | 18:0−20:4 | 2.5 ± 0.3 | 2.7 ± 0.2 |
812.6 | 18:0−20:3 | 1.4 ± 0.1 | 1.5 ± 0.1 |
814.6 | 18:0−20:2 | 1.0 ± 0.1 | 1.2 ± 0.2 |
816.6 | 18:1−20:0 | 5.6 ± 0.2 | 5.5 ± 0.2 |
834.6 | 18:0−22:6 | 2.8 ± 0.3 | 2.4 ± 0.2 |
836.6 | 18:0−22:5 | 0.6 ± 0.2 | 0.4 ± 0.1 |
842.7 | 18:1−22:1 | 3.4 ± 0.2 | 3.4 ± 0.1 |
844.7 | 18:0−22:1 | 11.2 ± 0.4 | 11.4 ± 0.2 |
858.7 | a18:0−24:1 | 2.6 ± 0.2 | 2.6 ± 0.1 |
870.7 | 18:1−24:1 | 4.2 ± 0.2 | 4.1 ± 0.1 |
872.7 | 18:0−24:1 | 15.4 ± 0.5 | 16.4 ± 0.6 |
Total GPSer | 148.5 ± 1.6 | 148.8 ± 4.5 |
[M - H]− | Phosphatidylinositol (GPIns) | ||
---|---|---|---|
833.6 | 16:0−18:2 GPIns | 1.5 ± 0.1 | 0.7 ± 0.1 |
835.6 | 16:0−18:1 GPIns | 1.2 ± 0.1 | 1.3 ± 0.1 |
857.6 | 16:0−20:4 GPIns | 0.8 ± 0.1 | 0.9 ± 0.1 |
859.6 | 18:1−18:2 GPIns | 0.8 ± 0.1 | 0.8 ± 0.1 |
861.6 | 18:1−18:1 GPIns | 3.2 ± 0.1 | 3.4 ± 0.2 |
863.6 | 18:0−18:1 GPIns | 1.8 ± 0.2 | 2.0 ± 0.1 |
883.6 | 18:1−20:4 GPIns | 0.4 ± 0.1 | 0.4 ± 0.1 |
885.6 | 18:0−20:4 GPIns | 4.7 ± 0.6 | 5.7 ± 0.2 |
887.6 | 18:0−20:3 GPIns | 2.8 ± 0.3 | 3.4 ± 0.1 |
889.6 | 18:0−20:2 GPIns | 2.5 ± 0.2 | 2.8 ± 0.2 |
909.6 | 18:0−22:6 GPIns | 0.4 ± 0.1 | 0.4 ± 0.1 |
911.6 | 18:0−22:5 GPIns | 0.1 ± 0.1 | 0.1 ± 0.1 |
Total GPIns | 20.1 ± 1.4 | 22.8 ± 0.5 |
[M - H]− | Ethanolamine glycerophospholipid (GPEtn) | ||
---|---|---|---|
646.5 | p16:0−14:0 | 0.1 ± 0.1 | 0.1 ± 0.1 |
672.5 | p14:0−18:1/p18:1−14:0/p16:0−16:1 | 1.0 ± 0.1 | 1.0 ± 1.0 |
674.5 | p16:0−16:0/p18:0−14:0 | 0.4 ± 0.1 | 0.4 ± 0.0.1 |
698.5 | p16:0−18:2/p18:2−16:0/p18:1−16:1 | 4.0 ± 0.2 | 4.0 ± 0.1 |
700.5 | p16:0−18:1/p18:1−16:0/p18:0−16:1 | 29.1 ± 1.7 | 28.7 ± 0.7 |
714.5 | d16:0−18:2/d16:1−18:1 | 5.5 ± 0.6 | 4.8 ± 0.1 |
716.5 | d16:0−18:1 | 7.9 ± 0.5 | 7.7 ± 0.1 |
722.5 | p16:0−20:4 | 2.4 ± 0.1 | 2.4 ± 0.1 |
724.5 | p18:1−18:2 | 9.9 ± 0.1 | 10.4 ± 0.8 |
726.5 | p18:1−18:1/p18:0−18:2/p20:1−16:1 | 93.6 ± 5.5 | 98.3 ± 3.7 |
728.5 | p18:0−18:1/p18:1−18:0/p20:1−16:0/p16:0−20:1/p20:0−16:1 | 73.8 ± 2.7 | 72.2 ± 2.1 |
738.5 | d16:0−20:4/d18:2−18:2 | 17.5 ± 0.8 | 18.2 ± 0.5 |
740.5 | d18:1−18:2/p19:1−18:1/p18:1−19:1 | 4.8 ± 1.0 | 3.7 ± 0.6 |
742.5 | d18:1−18:1/p19:0−18:1/p18:1−19:0 | 18.8 ± 1.1 | 19.9 ± 0.6 |
744.5 | d18:0−18:1 | 10.4 ± 0.5 | 10.1 ± 0.2 |
746.5 | p16:0−22:6 | 1.7 ± 0.1 | 1.6 ± 0.1 |
748.5 | p18:1−20:4/p16:0−22:5 | 10.7 ± 0.3 | 10.2 ± 0.7 |
750.5 | p18:0−20:4/p16:0−22:4 | 9.6 ± 0.3 | 9.2 ± 0.5 |
752.5 | p20:1−18:2 | 2.1 ± 0.1 | 2.2 ± 0.1 |
754.5 | p20:1−18:1/p20:0−18:2/p18:0−20:2/p16:0−22:2/d19:1−18:2/D19:2−18:1 | 4.1 ± 0.2 | 4.2 ± 0.2 |
756.5 | p20:0−18:1/d19:1−18:1/p18:0−20:1/p20:1−18:0 | 2.2 ± 0.1 | 2.2 ± 0.1 |
760.5 | d16:1−22:6 | 0.8 ± 0.1 | 0.8 ± 0.1 |
762.5 | d16:0−22:6/d16:1−22:5 | 3.3 ± 0.2 | 3.3 ± 0.2 |
764.5 | d16:0−22:5/d18:1−20:4 | 3.2 ± 0.1 | 3.1 ± 0.2 |
766.5 | d18:0−20:4 | 8.0 ± 1.2 | 7.3 ± 0.3 |
770.5 | p18:2−22:6 | 1.8 ± 0.1 | 1.9 ± 0.1 |
772.5 | p18:1−22:6 | 4.6 ± 0.1 | 4.5 ± 0.2 |
774.5 | p18:0−22:6 | 11.1 ± 0.8 | 10.2 ± 0.4 |
776.5 | p18:0−22:5/p18:1−22:4/p20:1−20:4 | 8.6 ± 0.2 | 8.6 ± 0.4 |
778.5 | p18:0−22:4/p20:0−20:4 | 8.5 ± 0.2 | 8.3 ± 0.3 |
780.5 | a20:0−20:4/p20:0−20:3/p18:0−22:3/d19:2−20:2 | 1.8 ± 0.2 | 1.8 ± 0.1 |
782.5 | p22:1−18:1/p18:1−22:1/d19:1−20:2/d19:2−20:1 | 2.7 ± 0.2 | 2.8 ± 0.1 |
784.5 | a18:1−22:1/p18:0−22:1/d19:1−20:1 | 1.8 ± 0.1 | 1.9 ± 0.1 |
788.5 | d18:1−22:6 | 1.6 ± 0.1 | 1.4 ± 0.1 |
790.5 | d18:0−22:6 | 9.6 ± 1.3 | 7.9 ± 0.6 |
792.5 | d18:0−22:5 | 1.4 ± 0.1 | 1.4 ± 0.1 |
794.5 | d20:0−20:4/d20:2−20:2/d18:0−22:4 | 2.1 ± 0.2 | 2.2 ± 0.1 |
796.5 | d20:1−20:2 | 0.7 ± 0.1 | 0.8 ± 0.1 |
798.5 | d20:1−20:1/d20:0−20:2/d18:1−22:1 | 2.0 ± 0.2 | 2.1 ± 0.1 |
800.5 | d20:1−20:0 | 1.5 ± 0.1 | 1.4 ± 0.1 |
802.5 | d18:0−22:0/p20:0−22:6 | 4.4 ± 0.2 | 4.5 ± 0.2 |
804.5 | p20:0−22:5 | 0.6 ± 0.1 | 0.7 ± 0.1 |
806.5 | p20:0−22:4 | 0.7 ± 0.1 | 0.7 ± 0.1 |
Total GPEtn | 390.1 ± 17.6 | 388.6 ± 11.4 | |
Total plasmalogen | 284.9 ± 11.4 | 286.0 ± 10.6 | |
Plasmalogen (%) | 73.0 ± 2.2 | 73.6 ± 1.6 |
[M + Li]+ | Choline glycerophospholipid (GPCho) | ||
---|---|---|---|
614.5 | a12:0−12:0 | 0.5 ± 0.2 | 0.6 ± 0.1 |
712.5 | d14:0−16:0 | 3.3 ± 0.2 | 3.5 ± 0.3 |
724.5 | p16:0−16:0 | 0.7 ± 0.1 | 1.0 ± 0.3 |
726.5 | a16:0−16:0 | 1.0 ± 0.3 | 1.1 ± 0.2 |
738.5 | d16:1−16:0 | 8.2 ± 1.0 | 6.3 ± 0.2 |
740.5 | d16:0−16:0 | 18.7 ± 1.9 | 16.0 ± 0.3 |
750.5 | p16:0−18:1 | 0.6 ± 0.2 | 0.9 ± 0.1 |
752.5 | p16:0−18:0 | 2.5 ± 0.5 | 2.9 ± 0.2 |
754.5 | a16:0−18:0 | 0.7 ± 0.1 | 0.5 ± 0.1 |
764.6 | d16:0−18:2 | 8.9 ± 1.7 | 10.1 ± 0.1 |
766.6 | d16:0−18:1 | 61.5 ± 4.6 | 59.2 ± 1.2 |
776.6 | p18:1−18:1 | 0.4 ± 0.3 | 0.6 ± 0.3 |
778.6 | p18:0−18:1 | 0.9 ± 0.2 | 0.9 ± 0.1 |
780.6 | p18:0−18:0 | 2.2 ± 0.2 | 1.9 ± 0.2 |
788.6 | d16:0−20:4/d16:1−20:3 | 6.5 ± 0.4 | 5.9 ± 0.1 |
790.6 | d18:1−18:2/d16:0−20:3 | 3.2 ± 0.5 | 3.4 ± 0.1 |
792.6 | d18:0−18:2/d18:1−18:1 | 8.9 ± 0.8 | 9.4 ± 0.1 |
794.6 | d18:0−18:1 | 19.3 ± 1.3 | 19.3 ± 0.2 |
812.6 | d16:0−22:6 | 12.6 ± 1.3 | 12.5 ± 0.5 |
814.6 | d18:1−20:4/d18:2−20:3 | 2.1 ± 0.4 | 1.4 ± 0.2 |
816.6 | d18:0−20:4/d18:2−20:2 | 5.5 ± 0.4 | 5.1 ± 0.3 |
818.6 | d18:0−20:3 | 1.2 ± 0.3 | 1.1 ± 0.4 |
830.6 | d19:0−20:4 | 0.5 ± 0.1 | 0.5 ± 0.1 |
836.6 | d18:2−22:6 | 0.6 ± 0.1 | 0.5 ± 0.1 |
838.6 | d18:1−22:6 | 1.4 ± 0.3 | 1.7 ± 0.1 |
840.6 | d18:0−22:6 | 3.2 ± 0.3 | 2.6 ± 0.1 |
848.6 | d20:1−20:1/d18:0−22:2 | 0.6 ± 0.3 | 0.8 ± 0.1 |
850.6 | d20:0−20:1/p20:1−22:6 | 3.4 ± 0.3 | 3.2 ± 0.1 |
864.6 | d20:2−22:6 | 0.3 ± 0.1 | 0.3 ± 0.1 |
876.6 | p22:3−22:5/d20:1−22:1 | 1.2 ± 0.1 | 1.0 ± 0.2 |
878.6 | p22:1−22:6/p22:6−22:1/d20:0−22:1 | 4.6 ± 0.6 | 6.1 ± 0.2 |
Total GPCho | 184.4 ± 5.5 | 180.1 ± 1.5 |
Mouse DRG lipids were extracted by a modified Bligh and Dyer procedure and the phospholipid molecular species in the lipid extracts were identified and quantified using a 2D ESI/MS technique as described under Materials and methods. The results are expressed in nmol/mg of protein and represent X ± SD of six different animals.
‘d’ (diacyl), ‘p’ (plasmenyl), and ‘a’ (alkyl) denote the three subclasses (i.e. phosphatidyl-, plasmenyl-, and plasmanyl-), respectively, in the classes of GPCho, GPEtn, and GPSer. DRG, dorsal root ganglia; WT, wild type; ApoE, apolipoprotein E; KO, knockout; DA, presence of a detectable ion peak.